Scribd Logo
Upload

Welcome to Scribd!

  • 350 views

    Nepafenac Drug Study

    Uploaded by

    Lucky Rius
    Nepafenac 0.1% ophthalmic suspension is a nonsteroidal anti-inflammatory drug (NSAID) used three times daily to treat eye pain, redness, and swelling after cataract surgery. It works by inhibiting prostaglandin production. Common adverse effects include capsular opacity, decreased vision, and foreign body sensation occurring in 5-10% of patients. Nursing responsibilities include monitoring for corneal breakdown and discontinuing use if it occurs, considering a history of NSAID hypersensitivity, and teaching proper administration and storage to avoid contamination.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Nepafenac Drug Study

    Uploaded by

    Lucky Rius
    350 views3 pages
    Nepafenac 0.1% ophthalmic suspension is a nonsteroidal anti-inflammatory drug (NSAID) used three times daily to treat eye pain, redness, and swelling after cataract surgery. It works by inhibiting prostaglandin production. Common adverse effects include capsular opacity, decreased vision, and foreign body sensation occurring in 5-10% of patients. Nursing responsibilities include monitoring for corneal breakdown and discontinuing use if it occurs, considering a history of NSAID hypersensitivity, and teaching proper administration and storage to avoid contamination.

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Nepafenac 0.1% ophthalmic suspension is a nonsteroidal anti-inflammatory drug (NSAID) used three times daily to treat eye pain, redness, and swelling after cataract surgery. It works by inhibiting prostaglandin production. Common adverse effects include capsular opacity, decreased vision, and foreign body sensation occurring in 5-10% of patients. Nursing responsibilities include monitoring for corneal breakdown and discontinuing use if it occurs, considering a history of NSAID hypersensitivity, and teaching proper administration and storage to avoid contamination.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    350 views3 pages

    Nepafenac Drug Study

    Uploaded by

    Lucky Rius
    Nepafenac 0.1% ophthalmic suspension is a nonsteroidal anti-inflammatory drug (NSAID) used three times daily to treat eye pain, redness, and swelling after cataract surgery. It works by inhibiting prostaglandin production. Common adverse effects include capsular opacity, decreased vision, and foreign body sensation occurring in 5-10% of patients. Nursing responsibilities include monitoring for corneal breakdown and discontinuing use if it occurs, considering a history of NSAID hypersensitivity, and teaching proper administration and storage to avoid contamination.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 3

    Name of Dosage, Mechanism of Indication Contraindication Adverse Effect Nursing Responsibility

    Drug Route and Action


    Frequency
    Generic Dosage: After topical ocular Ophthalmic - Hypersensitivity to - The most Interventions:
    Name: dosing, nepafenac nepafenac is used the active substance frequently reported
    penetrates the cornea to treat eye pain, ocular adverse events
    1 gtts and is converted by redness, and following cataract - Consider the history of
    Nepafenac ocular tissue swelling in - Hypersensitivity to surgery were hypersensitivity to the drugs or one
    0.1%, oph. hydrolases to patients who are other nonsteroidal capsular opacity, of its components
    susp Frequency: amfenac, a recovering from anti-inflammatory decreased visual
    nonsteroidal anti- cataract surgery drugs (NSAIDs). acuity, foreign body
    inflammatory drug. (procedure to sensation, increased - Monitor cornea; discontinue if
    Amfenac is thought treat clouding of intraocular pressure, corneal epithelial breakdown
    Brand Name: TID
    to inhibit the action the lens in the - Patients in whom and sticky sensation. occurs
    of prostaglandin H eye). Nepafenac attacks of asthma, These events
    synthase is in a class of urticaria, or acute occurred in
    Nevanac Route: (cyclooxygenase), an medications rhinitis are approximately 5 to
    - If more than one topical
    enzyme required for called precipitated by 10% of patients.
    ophthalmic medication is being
    prostaglandin nonsteroidal anti- acetylsalicylic acid
    Opthalmic Other ocular adverse used, the medicines must be
    production. inflammatory
    Route OU events occurring at administered at least 5 minutes
    drugs (NSAIDs). or other NSAIDs.
    Classification: an incidence of interval.
    It works by
    approximately 1 to
    stopping the - Apply eyedrops and ointment
    5% included
    production of from less concentrated to more
    Nonsteroidal conjunctival edema,
    certain natural concentrated texture.
    Anti- corneal edema, dry
    substances that
    inflammatory eye, lid margin
    cause pain and
    Drug crusting, ocular
    swelling. Teaching Points:
    discomfort, ocular
    hyperemia, ocular
    pain, ocular pruritus,
    photophobia, tearing - Patients should be informed of the
    and vitreous possibility that slow or delayed
    healing may occur while using
    detachment. nonsteroidal anti-inflammatory
    drugs.

    Other
    contraindications: - Patients should be instructed to
    avoid allowing the tip of the
    - Bleeding
    dispensing container to contact the
    tendencies
    eye or surrounding structures
    - May delay wound because this could cause the tip to
    healing become contaminated by common
    bacteria known to cause ocular
    - Rheumatoid infections.
    arthritis
    - Diabetes
    - Serious damage to the eye and
    - Contact lenses subsequent loss of vision may
    (remove during result from using contaminated
    therapy) solutions.
    - Pregnancy (avoid
    during 3rd trimester)
    - Nursing mothers - Instruct patient nevanac should
    not be administered while wearing
    contact lens.

    - Patients should be advised that if


    they develop an intercurrent ocular
    condition (e.g., trauma, or
    infection) or have ocular surgery,
    they should immediately seek their
    physician’s advice concerning the
    continued use of the multidose
    container.
    - Patients should be advised to
    shake the bottle well.

    You might also like